We help founders build the most disruptive companies at the edge of Synthetic Biology and A.I. or Quantum Computing
Our mission is to contribute to the development of the most disruptive companies who want to enable humanity to face up to its next challenges as a species from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.
We are deeply focused on founders and supporting their businesses with capital, time, industry insights and mentorship. We invest in founders who have a vision for what's possible.
We are patient investors and are not flustered by day-to-day conditions. We delay gratification and invest in business that will change the world over time.
We believe that being as short and direct as possible. Providing information the shortest path the flow will allow us to act quickly for the benefit of our founders.
We have a bias for action. Bring that super hardcore work ethic with you everyday.
With more than 4,000 startups from pre-seed to Serie C in our ecosystem aligned with our vision, we launched Next Sequence to help founders build the most disruptive companies who want to enable humanity to face up to its next challenges as a species from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.
Officially launched OpenSynBio, a non for profit Computing Foundation for Synthetic Biology with mission to build the largest community of researchers, startups and industrial partners who collaborate together to develop and run the most disruptive computing technologies advancing fundamental and applied research in Synthetic Biology.
Started working on developing predictive algorithms for biotechnology startups and realized that the innovation engine in life science was ultimately broken when it comes to computing.
-modified-v2.png)
